Independent report: RAPID C-19 Oversight Group report: review of Evusheld

Independent report: RAPID C-19 Oversight Group report: review of Evusheld  summary of the evidence on efficacy of Evusheld as a prophylactic treatment for coronavirus (COVID-19) considered by the RAPID C-19 Oversight Group. Department of Health and Social Care

See also:

• Research: COVID-19 vaccine weekly surveillance reports (weeks 39 to 40, 2021 to 2022) UK Health Security Agency
• Guidance: COVID-19: guidance for people whose immune system means they are at higher risk UK Health Security Agency
• National flu and COVID-19 surveillance reports published UK Health Security Agency